Artificial Intelligence in Transfusion Medicine: From Donor Recruitment to Hemovigilance
Radheshyam Meher, Senior Resident at AIIMS, psoted on LinkedIn:
”Exciting Announcement
I am honored to serve as Guest Editor for a special collection in Cureus on:
“Artificial Intelligence in Transfusion Medicine: From Donor Recruitment to Hemovigilance”
This collection will highlight how AI is reshaping every step of the transfusion medicine journey, from innovative donor recruitment and retention strategies to predictive inventory management, AI-driven blood safety and pathogen detection, automated hemovigilance, and advanced clinical decision support.
We welcome original research, reviews, case studies, and perspectives that showcase both technological innovation and real-world applications, while also addressing the ethical and regulatory challenges of AI in healthcare.
Our aim is to bring together a global, interdisciplinary perspective that bridges digital health, transfusion science, and clinical practice, ultimately driving improvements in efficiency, safety, and patient outcomes.
Topics include (but are not limited to):
- AI for donor recruitment and retention
- Predictive analytics for transfusion needs
- Machine learning in inventory management
- Automated hemovigilance and adverse event monitoring
- AI in therapeutic apheresis and cellular therapies
- NLP in transfusion data
- Ethical and regulatory considerations
I invite researchers, clinicians, data scientists, and innovators to submit your work and be part of this forward-looking initiative.
Let’s work together to shape the future of AI in Transfusion Medicine.
Submit here.”
Stay updated with Hemostasis Today.
-
Mar 17, 2026, 15:41Beverly G. Tchang: Lipid-Lowering Therapy in Women During Pregnancy and Lactation
-
Mar 17, 2026, 15:34Folusho Adeosun: Raising Fetal Hemoglobin as a Powerful Protective Shield in Sickle Cell Disease
-
Mar 17, 2026, 15:28Aafreen Kotadiya: Why a Great Blood Bank Team is a Rare and Powerful Asset in Transfusion Medicine
-
Mar 17, 2026, 15:26Nathan Connell: $50 Million Gift to Advance Cell and Gene Therapy at Mass General Brigham
-
Mar 17, 2026, 15:10Peter Zdziarski: Standing Together for Ultra Rare Bleeding Disorders Awareness Day
-
Mar 17, 2026, 14:58Heghine Khachatryan: PFO, Cryptogenic Stroke, and Factor V Leiden – Closure or Lifelong Anticoagulation?
-
Mar 17, 2026, 14:56Mahesan Subramaniam: A Visual Guide to Heart Valve Disease
-
Mar 17, 2026, 14:55Daniel Victor Ortigoza: Apixaban Shows Lower Bleeding Risk than Rivaroxaban in Acute VTE
-
Mar 17, 2026, 14:52Kanishk Kumar: ATTR Amyloidosis Therapeutics Market Poised for a Pipeline Revolution